PolarSeal®, the flexible medical device partner, today announces the appointment of Chris Locke as Chief Technology Officer (CTO) – a key strategic move that reinforces its commitment to enabling innovation in MedTech solutions.
Chris Locke brings over two decades of global experience in medical device R&D, technology strategy, and organisational transformation. His impressive track record includes senior leadership roles at Acelity/KCI, and Vyaire Medical, where he built and led high-performing teams to deliver breakthrough technologies across wound care, surgical, and life sciences applications. With close to 500 granted US patents in wound care and NPWT, Chris exemplifies fearless innovation – transforming ideas into real-world solutions that shape the future of MedTech.
At PolarSeal, Chris will drive the next phase of technological advancement, combining product, technology & process innovation, R&D acceleration, and scalable production strategies to help clients bring breakthrough medical devices to market faster and smarter. He will lead engineering teams to solve complex challenges across the device lifecycle, helping clients navigate from concept to commercialisation with confidence.
Oliver Law, Chief Executive Officer, PolarSeal said:
“Chris is more than an R&D leader – he’s an innovation architect who knows how to transform bold ideas from concept to scalable production. His ability to fuse clinical insight, technical mastery, and operational rigour will be key as we continue to position PolarSeal as the go-to partner for disruptive healthcare technologies.
“At a time when MedTech innovators are under pressure to move faster and deliver smarter, Chris’s leadership will help us unlock new possibilities, for our clients and the patients they serve. He will play a key role in sharpening our edge and bringing fresh thinking to how we tackle real-world challenges.”
This appointment reinforces PolarSeal’s role as an innovation partner that leads with vision, acts with confidence, and builds with precision. Chris’s leadership will directly support PolarSeal’s global partners in bringing high-performance, flexible medical devices to market – faster, smarter, and with unwavering quality.
Chris commented: “PolarSeal has that rare mix of agility, deep healthcare industry experience, prototyping & manufacturing expertise and creative ambition. I’m excited to join a team that doesn’t just deliver components but thinks bigger – to create tomorrow’s solutions that improve lives today. There’s so much we can achieve with PolarSeal’s technologies and global manufacturing presence, and together, we’ll push the boundaries of MedTech.”
With facilities in the UK and US, ISO 13485 certification, and FDA-registered cleanroom operations, PolarSeal continues to expand its footprint as the trusted innovation partner for MedTech leaders in wound care, surgical, wearable, and life science sectors.
